Olberon Ltd, a medical device innovation company based in Nottingham, has recently appointed TB Medex SAS as their Affiliate Partner MEA.

This is the first appointment as part of Olberon’s ambitious global growth programme, for its unique portfolio of products which includes the Otorhinoscope and the Vacuderm.

CEO, Dr Arash Bakhtyari explained ‘We are very pleased to have agreed terms with TB Medex SAS who are renowned in the MEA region for rapidly creating brand market leaders in their categories. This is the first appointment among many globally we hope to complete this year with two of our unique products developed by ourselves here in Nottingham.”

The VACUDERM, is a single-use tourniquet for difficult to reach veins with a unique suction and pump mechanism to aid further filling of the veins. It has been designed to aid intravenous needle insertion for cannulation, blood collection and drug delivery. A version for children is currently being developed to distract them and encourage them to ‘assist’ the procedure by pumping the dome.

The OTORHINOSCOPE, is a handheld diagnostic device for both ear and nasal cavities for essential examination, with a unique dual-purpose expandable single-use speculum.

Olberon was set up in 2005 in the UK and have accomplished a strong portfolio of in-house patented medical innovations, two medical devices that are market ready from concept to commercialisation, as well as offering consultancy services to both the NHS and the wider medical device market.

TBMedex SAS is a professional organisation that assists medical companies in developing their brands in the MEA region. TBMedex SAS represents renowned international companies and has helped medical manufacturers in exporting to more than 20 markets in the MEA Region, and rapidly creating brand market leaders in their categories. Their services include: Regional Distribution, Distributor Search & Selection, Market Research, Contract Negotiating & Facilitating, Sales Strategy Development & Implementation.

To find out more, please visit the Olberon website.

Latest Opportunities

Exporting Starts Here programme for West Midlands companies

West Midlands Combined Authority (WMCA), funded by the UK Shared Prosperity Fund (UKSPF), has commissioned…

NIHR i4i Connect funding call

The NIHR Invention for Innovation (i4i) programme is accepting outline applications to their latest researcher-led Connect funding…

Study brief: The effects of a recovery gel on endurance cycling performance in the heat

The popularity of endurance sports like cycling and running has grown significantly over the past…

Latest News

Blog: Why cleanrooms are essential for medical-grade cannabis companies

By Medilink Midlands Member Airology Systems The demand for medical-grade cannabis has surged in recent…

Australia’s Cannim partners with PHTA to advance medicinal cannabis research

Leading medicinal cannabis company Cannim has announced its UK operations will be based at Birmingham’s…

New sleep trial shows dramatic benefits for participants

Cambridge Sleep Sciences (CSS), a leading UK innovator in sleep technology, has announced groundbreaking results…